Reforming tuberculosis control in Ukraine: Results of pilot projects and implications for the national scale-up of DOTS

Health Policy and Planning

Volumn 24, Issue 1, 2009, Pages 55-62

  Vassall, A ^a,h   Chechulin, Y ^b   Raykhert, I ^c   Osalenko, N ^d   Svetlichnaya, S ^e   Kovalyova, A ^e   Van Der Werf, M J ^f   Turchenko, L V ^d   Hasker, E ^b   Miskinis, K ^c   Veen, J ^f   Zaleskis, R ^g  

^a ROYAL TROPICAL INSTITUTE   (Netherlands)

^b Project Tuberculosis Prevention and Control in Kiev City Ukraine   (Ukraine)

^c WHO Pilot Project Office for TB Control in Donetsk Oblast   (Ukraine)

^d Kiev City TB Department   (Ukraine)

^e Donetsk Oblast TB Hospital   (Ukraine)

^f KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^g WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

^h NONE   (Netherlands)

Author keywords

Disincentives; DOTS; MDR TB; Scale up; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; COST EFFECTIVENESS ANALYSIS; ECONOMICS; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MEDICAL FEE; MEDICAL PRACTICE; MULTIDRUG RESISTANCE; PILOT STUDY; SHORT COURSE THERAPY; TUBERCULOSIS; UKRAINE;

COST-BENEFIT ANALYSIS; DIRECTLY OBSERVED THERAPY; FEASIBILITY STUDIES; HEALTH CARE REFORM; HEALTH EXPENDITURES; HEALTH POLICY; HUMANS; PILOT PROJECTS; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; UKRAINE;

EID: 58149139699     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czn045     Document Type: Article

References (15)

1. Atun RA, Samyshkin YA, Drobniewski F et al. 2005. Social factors influencing hospital utilisation by tuberculosis patients in the Russian Federation: analysis of routinely collected data. International Journal of Tuberculosis and Lung Disease 9: 1140-6.
2. Coker RJ, Atun RA, McKee M. 2004. Health-care system frailties and public health control of communicable disease on the European Union's new eastern border. The Lancet 363: 1389-92.
3. Drobniewski F, Nikolayevsky V, Asmolov A, Bazhora Y, Servetsky S. 2005. Increasing trends in HIV and TB rates in Odessa and the Ukraine. International Journal of STD & AIDS 16: 374-8.
4. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. 1997. Methods for the economic evaluation of health care programmes. Second edition. Oxford: Oxford University Press.
5. Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG. 2002. Worldwide incidence of multidrug-resistant tuberculosis. Journal of Infectious Diseases 185: 1197-202.
6. Floyd K. 2002. Guidelines for cost and cost-effectiveness analysis of tuberculosis control. Geneva: World Health Organization. WHO/CDS/TB/2002.305a.
7. Hamers FF, Downs AM. 2003. HIV in central and eastern Europe. The Lancet 361: 1035-44.
8. Jacobs B, Clowes C, Wares F et al. 2002. Cost-effectiveness analysis of the Russian treatment scheme for tuberculosis versus short-course chemotherapy: results from Tomsk, Siberia. International Journal of Tuberculosis and Lung Disease 6: 396-405.
9. Migliori GB, Khomenko AG, Punga VV et al. 1998. Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast. Bulletin of the World Health Organization 76: 475-83.
10. Tan-Torres Edejer T, Baltussen R, Adam T et al. 2003. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization.
11. Van der Werf MJ, Chechulin Y, Yegorova OB et al. 2006. Health care seeking behaviour for TB symptoms in Kyiv City, Ukraine. International Journal of Tuberculosis and Lung Disease 10: 390-5.
12. Walker D, Kumaranayake L. 2002. Allowing for differential timing in cost analyses: discounting and annualization. Health Policy and Planning 17: 112-8.
13. World Bank. 2005. Ukraine at a glance. Washington, DC: World Bank.
14. WHO. 1997. Treatment of tuberculosis: guidelines for national programmes. WHO/TB/97.220. Geneva: World Health Organization.
15. WHO. 1999. What is DOTS? A guide to understanding the WHO-recommended TB control strategy known as DOTS. Geneva: World Health Organization. WHO/CDS/CPC/TB/99.270.